hysteroscopy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Scheduled for the patients who undergone hysteroscopy, aged 20 to 52 years old, BMI in 17 ~ 27 kg/m2, ASA I-II ;Inclusion criteria: Scheduled for the patients who undergone hysteroscopy, aged 20 to 52 years old, BMI in 17 ~ 27 kg/m2, ASA I-II ;Inclusion criteria: Scheduled for the patients who undergone hysteroscopy, aged 20 to 52 years old, BMI in 17 ~ 27 kg/m2, ASA I-II ;Inclusion criteria: Scheduled for the patients who undergone hysteroscopy, aged 20 to 52 years old, BMI in 17 ~ 27 kg/m2, ASA I-II ;Inclusion criteria: Scheduled for the patients who undergone hysteroscopy, aged 20 to 52 years old, BMI in 17 ~ 27 kg/m2, ASA I-II
Exclusion criteria
Exclusion criteria: Patients with a history of severity heart and lung diseases, psychiatric disease, allergy or hypersensitivity to local anesthetics and long-term administration of analgesics were excluded. ;Exclusion criteria: Patients with a history of severity heart and lung diseases, psychiatric disease, allergy or hypersensitivity to local anesthetics and long-term administration of analgesics were excluded. ;Exclusion criteria: Patients with a history of severity heart and lung diseases, psychiatric disease, allergy or hypersensitivity to local anesthetics and long-term administration of analgesics were excluded. ;Exclusion criteria: Patients with a history of severity heart and lung diseases, psychiatric disease, allergy or hypersensitivity to local anesthetics and long-term administration of analgesics were excluded. ;Exclusion criteria: Patients with a history of severity heart and lung diseases, psychiatric disease, allergy or hypersensitivity to local anesthetics and long-term administration of analgesics were excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Propofol induced dosage;Propofol maintenance dosage;Propofol total dosage;total propofol administration time;the consumption of propofol per minute;operation time;operation time;body movement;emergence time;discharge time;occurrence of adverse cardiovascular events;hypoxemia;adverse reactions;visual analogue scale;blood pressure;heart rate;pulse oxygen saturation; | — |
Countries
China
Contacts
Wenzhou People's Hospital;Wenzhou People's Hospital;Wenzhou People's Hospital;Wenzhou People's Hospital;Wenzhou People's Hospital